Skip to main content

CASE REPORT article

Front. Cardiovasc. Med., 26 July 2024
Sec. Cardiac Rhythmology
This article is part of the Research Topic Case Reports in Cardiac Rhythmology: 2024 View all 4 articles

Left bundle branch pacing in third-degree atrioventricular block following morrow surgery: a case report

\r\nKeqiang HuangKeqiang HuangHongmei GanHongmei GanJingjing JiangJingjing JiangCheng Tang
\r\nCheng Tang*
  • Department of Cardiology, Wuhan Asia General Hospital, Wuhan, Hubei, China

Left bundle branch pacing (LBBP) has proven to be an alternative method for delivering physiological pacing to achieve electrical synchrony of the left ventricle (LV), especially in patients with atrioventricular block and left bundle branch block (LBBB). However, it is unclear whether it still achieved in patients whose left bundle branch (LBB) has had surgery-induced damage. The Morrow operation (Morrow septal myectomy) is regarded as one of the most effective treatments for hypertrophic obstructive cardiomyopathy (HOCM). The surgery resects small sections of muscle tissue in the proximal ventricular septum nearby or contains the LBB, which means that physical damage to the LBB is almost inevitable. Approximately 2%–12% of patients may need pacemaker implanted after Morrow surgery. LBBP is a feasible and effective method for achieving electric resynchronization of LBBB compared to right ventricular pacing (RVB). Nevertheless, there is a dearth of data on LBBP in third-degree atrioventricular block (AVB) following Morrow surgery. We report a case of successful LBBP in those patients.

Introduction

Left bundle branch pacing (LBBP) has proven to be an alternative method for delivering physiological pacing to achieve electrical synchrony of the left ventricle (LV), especially in patients with atrioventricular block and left bundle branch block (LBBB) (1). However, it is unclear whether it still achieved in patients whose left bundle branch (LBB) has had surgery-induced damage.

The Morrow operation (Morrow septal myectomy) is regarded as one of the most effective treatments for hypertrophic obstructive cardiomyopathy (HOCM). The surgery resects small sections of muscle tissue in the proximal ventricular septum nearby or contains the LBB, which means that physical damage to the LBB is almost inevitable (2). Approximately 2%–12% of patients may need pacemaker implanted after Morrow surgery (3, 4).

LBBP is a feasible and effective method for achieving electric resynchronization of LBBB compared to right ventricular pacing (RVB). Nevertheless, there is a dearth of data on LBBP in third-degree atrioventricular block (AVB) following Morrow surgery. We report a case of successful LBBP in those patients.

Key teaching points

• LBBP was achieved in the patient who received LBB and third-degree AVB following Morrow surgery.

• LBB is an area of the left ventricular septum instead of an electric wire, so even if the surgery physically damages it, it is not possible to affect all the electrical conduction characteristics of LBB.

• Physically damaged LBBB cannot be corrected by His-bundle pacing (HBP). Usually, no LBB potential can be recorded.

• The ECG characteristics [paced QRS morphology, paced QRS duration and stimulus to peak left ventricular activation time (Sti-LVAT)] could be evidence of LBB capture.a

Case report

A 55-year-old woman presented with symptoms of chest distress and syncope for 10 years. Ecg showed sinus bradycardia, right bundle branch block (RBBB) and left ventricular hypertrophy (Figures 1A, 2A). Echocardiography examination revealed the septum below the aortic valve; ventricular septal hypertrophy with left ventricular outflow tract stenosis; mild aortic stenosis and severe regurgitation; and enlargement of the ascending aorta.

Figure 1
www.frontiersin.org

Figure 1 (A) A diagram of the right bundle branch block before MORROW surgery. The black square indicates that there was a block in the right bundle branch. (B) A diagram of how the left bundle branch has been damaged by the scalpel in MORROW surgery. The rhythm of the ventricle comes from under the block site of the RBB (the blue arrow). (C) A diagram of the His bundle potential recorded by the first 3830 lead. (D) A diagram of the 3830 pacing lead advanced from the right ventricular septum (RVS) to the left ventricular septum (LVS) in the subendocardium, and the lead captured the LBB under the damaged part caused by MORROW surgery (the green arrow). (E) A diagram of 3830 pacing lead capturing the LBB and the myocardium at the same time (the green arrow). (F) A diagram of 3830 pacing lead capturing the LBB and the right ventricular myocardium by the ring at the same time (the green arrow) after planting the permanent pacemaker.

Figure 2
www.frontiersin.org

Figure 2 (A) ECG before MORROW surgery. ECG showed sinus bradycardia, RBBB and left ventricular hypertrophy (QRS duration:126 ms). (B) ECG showed 3rd degree AVB 7 days after MORROW surgery(QRS duration:130 ms). (C) The His bundle potential follows behind the atrial potential, but it cannot capture the ventricle activation or LBB even at high voltage (10 v/1 ms). (D) There was an abrupt shortening of Sti-LVAT from 100 ms to 76 ms while the pacing lead advanced from the RVS to the LVS in the subendocardium. (E) Sti-LVAT remains the same at low and high voltages (2 V and 10 V). (F) The ECG of the pacemaker, the morphology of the premature ventricle was the same as before the pacemaker was implanted(QRS duration:114 ms). (G) Electrocardiogram at the 6-month follow-up after pacemaker implantation.

A Bentall + Subaortic septum resection + Morrow surgery was performed, and a transepicardial temporary pacing lead was implanted when the ECG monitor showed complete atrioventricular block (AVB) after the heart resumes beating.

After 7 days of observation, ECG still showed 3rd degree AVB (Figures 1B, 2B), so the patient was indicated for permanent dual-chamber pacemaker implantation, and LBBP was performed. The pace lead (Model 3830; SelectSecure, Medtronic, Minneapolis, MN) was successfully implanted, and both paced and intrinsic intracardiac EGM and ECG were continuously recorded while the pacing lead advanced from the right ventricular septum (RVS) to the left ventricular septum (LVS) in the subendocardium, with a unipolar pacing output of 2 V/0.5 ms.

After locating the tricuspid valve annulus (TVA) and tricuspid septal leaflet by right ventriculography (Supplementary Video S1), it was easy to identify the HBP site and locate the His bundle potential following the atrial potential, but it could not capture the ventricular activation or LBB even at high voltage (10 v/1 ms) (Figures 1C, 2C).

A second 3830 lead was implanted to LBBP, and there was an abrupt shortening of Sti-LVAT from 100 ms to 76 ms while the pacing lead advanced from the RVS to the LVS in the subendocardium with a unipolar pacing output of 2 V/0.5 ms (Figures 1D, 2D). The Sti-LVAT remains the same at low and high voltages (2 V and 10 V) (Figures 1E, 2E). However, no LBB potential was recorded even with HBP at a high voltage (10 V).

The depth of lead insertion was approximately 1.3–1.5 cm by angiography through the C315 sheath (Supplementary Video S2). The QRS was narrow (124 ms) after implanting the permanent pacemaker, but there was frequent monomorphous ventricular premature beats, and the morphology of the premature ventricle was the same as before the pacemaker was implanted (Figures 1F, 2F).

Discussion

Many studies have demonstrated that LBBP is feasible in LBBB patients and that the LBB potential could be recorded during His bundle pacing. However, whether it still works in patients whose LBB has suffered physical damage as a result of surgery, such as MORROW, has not been in-depth coverage. Past studies have mentioned that pacing of the conduction system is feasible in patients with hypertrophic cardiomyopathy. Jing-Jing and her colleagues' research (5) has demonstrated that CSP was safe and feasible in patients with HCM and cardiac dysfunction, and did not worsen cardiac performance especially in patients with LVEF <50%. HBP might be an effective alternative to LBBP in patients with significantly thickened interventricular septum. But in our case, the physical resection of the left bundle branch made His-bundle pacing unfeasible.

In this patient, RBBB existed before MORROW surgery, and a 3rd degree AVB was inevitably following the surgery, which almost certainly damaged the LBB. During pacemaker implantation, the His bundle potential was recorded behind the atrial potential (Figure 2C), which means that the block site was under the His bundle. HBP was not able to capture the ventricle activation or LBB even at high voltage (10 V/1 ms), indicating that HBP may not be effective in this kind of patient. Additionally, we supposed that it still did not work even if the patient had no RBBB before the surgery because the path from the His bundle to the LBB was damaged by the surgery.

Although the LBB potential could not be recorded after the physical damage caused by the surgery, there are various alternatives to confirm LBBP, including monitoring the paced QRS morphology when the mid notch of the QRS complex moves up and toward the end in lead V1. The paced ECG QRS morphology frequently presents as RBBB morphology with a low threshold. More direct evidence comes from the abrupt shortening of Sti-LVAT as the pacing lead advanced from the RVS to the LVS in the subendocardium with a unipolar pacing output of 2 V/0.5 ms (Figure 2D). More importantly, thanks to the help of John Jiang's connecting cable which consists of a rotatable port and a connection wire (6). We could continuously monitor and test during the procedure. Finally, LVAT remained the same at low- and high-output pacing. It also confirmed that the final implantation site of the LBBP was adjacent to the left conduction system (7).

In conclusion, LBBP could be obtained in patients who received LBB caused by physical damage from surgery, such as the Morrow surgery. There are various techniques to confirm LBBP. Further data are required to confirm whether it works in all of these kinds of patients.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Ethics statement

Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.

Author contributions

KH: Writing – original draft, Writing – review & editing. HG: Writing – original draft, Writing – review & editing. JJ: Writing – original draft, Writing – review & editing. CT: Writing – original draft, Writing – review & editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article.

Funding for this research was provided by Wuhan Medical Research Project (Grant Number: WX21Z11 and WX20A01)

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcvm.2024.1391047/full#supplementary-material

References

1. Huang W, Su L, Wu S, Xu L, Xiao F, Zhou X, et al. A novel pacing strategy with low and stable output: pacing the left bundle branch immediately beyond the conduction block. Can J Cardiol. (2017) 33:1736.e1–3. doi: 10.1016/j.cjca.2017.09.013

PubMed Abstract | Crossref Full Text | Google Scholar

2. Wang S, Luo M, Sun H, Song Y, Yin C, Wang L, et al. A retrospective clinical study of transaortic extended septal myectomy for obstructive hypertrophic cardiomyopathy in China. Eur J Cardiothorac Surg. (2013) 43:534–40. doi: 10.1093/ejcts/ezs332

PubMed Abstract | Crossref Full Text | Google Scholar

3. Lai Y, Guo H, Li J, Dai J, Ren C, Wang YJM. Comparison of surgical results in patients with hypertrophic obstructive cardiomyopathy after classic or modified morrow septal myectomy. Medicine. (2017) 96:e9371–5. doi: 10.1097/MD.0000000000009371

PubMed Abstract | Crossref Full Text | Google Scholar

4. Kwon DH, Smedira NG, Thamilarasan M, Lytle BW, Lever H, Desai MY, et al. Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation. J Thorac Cardiovasc Surg. (2010) 140:317–24. doi: 10.1016/j.jtcvs.2009.10.045

PubMed Abstract | Crossref Full Text | Google Scholar

5. Jing-Jing J, Ke-Xin W, Zhao-Meng J, Nan W, Lian-Jun G, Yun-Long X, et al. Conduction system pacing for ventricular pacing requirement is feasible and effective on patients with hypertrophic cardiomyopathy and cardiac dysfunction. Int J Cardiol Heart Vasc. (2023) 49:101296. doi: 10.1016/j.ijcha.2023.101296

PubMed Abstract | Crossref Full Text | Google Scholar

6. Zhong J, Zheng N, Jiang LJHRO. Evaluation of the shortening of the stimulus-to-peak left ventricular activation time at continuous low output to confirm selective left bundle branch pacing. Heart Rhythm O2. (2022) 3:351–7. doi: 10.1016/j.hroo.2022.04.006

PubMed Abstract | Crossref Full Text | Google Scholar

7. Huang W, Chen X, Su L, Wu S, Xia X, Vijayaraman PJHR. A beginner’s guide to permanent left bundle branch pacing. Heart Rhythm. (2019) 16:1791–6. doi: 10.1016/j.hrthm.2019.06.016

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: left bundle area pacing, left bundle block, morrow, septal myectomy, pacemaker

Citation: Huang K, Gan H, Jiang J and Tang C (2024) Left bundle branch pacing in third-degree atrioventricular block following morrow surgery: a case report. Front. Cardiovasc. Med. 11: 1391047. doi: 10.3389/fcvm.2024.1391047

Received: 24 February 2024; Accepted: 11 July 2024;
Published: 26 July 2024.

Edited by:

Richard Hauer, University Medical Center Utrecht, Netherlands

Reviewed by:

Javier Eduardo Banchs, Scott & White Memorial Hospital, United States
Gerard J. J. Boink, University of Amsterdam, Netherlands

© 2024 Huang, Gan, Jiang and Tang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Cheng Tang, 360830037@qq.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.